Influence of phosphorus dendrimers on the aggregation of the prion peptide PrP 185-208

Biochemical and Biophysical Research Communications

Volumn 364, Issue 1, 2007, Pages 20-25

  Klajnert, Barbara ^a   Cortijo Arellano, Marta ^b   Cladera, Josep ^b   Majoral, Jean Pierre ^c   Caminade, Anne Marie ^c   Bryszewska, Maria ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c LCC LABORATOIRE DE CHIMIE DE COORDINATION   (France)

Author keywords

Aggregation; Amyloid; Dendrimer; Fibril; Polymer; Prion disease

Indexed keywords

AMYLOID; DENDRIMER; MONOMER; OLIGOMER; PHOSPHORUS DENDRIMER; PHOSPHORUS DERIVATIVE; PRION PROTEIN; THIOFLAVINE; UNCLASSIFIED DRUG;

ARTICLE; CELL AGGREGATION; INFRARED SPECTROMETRY; KINETICS; PRIORITY JOURNAL; PROTEIN STRUCTURE; SPECTROFLUOROMETRY;

AMINO ACID SEQUENCE; AMYLOID; DENDRIMERS; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHOSPHORUS; PRIONS; PROTEIN STRUCTURE, SECONDARY; PRPC PROTEINS; SPECTROMETRY, FLUORESCENCE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THIAZOLES;

EID: 35349030840     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.09.083     Document Type: Article

References (33)

1. Prusiner S.B. Scrapie prions. Annu. Rev. Microbiol. 43 (1989) 345-374
2. Farquhar C.F., and Dickinson A.G. Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection. J. Gen. Virol. 67 (1986) 463-473
3. McKenzie D., Kaczkowski J., Marsh R., and Aiken J. Amphotericin B delays both scrapie agent replication and PrP-res accumulation early in infection. J. Virol. 68 (1994) 7534-7536
4. Ingrosso L., Ladogana A., and Pocchiari M. Congo red prolongs the incubation period in scrapie-infected hamsters. J. Virol. 69 (1995) 506-508
5. Tagliavini F., McArthur R.A., Canciani B., Giaccone G., Porro M., Bugiani M., Lievens P.M.-J., Bugiani O., Peri E., Dall'Ara P., Rocchi M., Poli G., Forloni G., Bandiera T., Varasi M., Suarato A., Cassutti P., Cervini M.A., Lansen J., Salmona M., and Post C. Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science 276 (1997) 1119-1122
6. Manuelidis L., Fritch W., and Zaitsev I. Dapsone to delay symptoms in Creutzfeldt-Jakob disease. Lancet 352 (1998) 456
7. Adjou K.T., Demaimay R., Deslys J.-P., Lasmézas C.L., Beringue V., Demart S., Lamoury F., Seman M., and Dormont D. MS-8209, a watersoluble amphotericin B derivative, affects both scrapie agent replication and PrP accumulation in Syrian hamster scrapie. J. Gen. Virol. 80 (1999) 1079-1085
8. Farquhar C., Dickinson A., and Bruce M. Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies. Lancet 353 (1999) 117
9. Priola S.A., Raines A., and Caughey W.S. Porphyrin and phthalocyanine antiscrapie compounds. Science 287 (2000) 1503-1506
10. Soto C., Kascsak R.J., Saborío G.P., Aucouturier P., Wisniewski T., Prelli F., Kascsak R., Mendez E., Harris D.A., Ironside J., Tagliavini F., Carp R.I., and Frangione B. Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides. Lancet 355 (2000) 192-197
11. Supattapone S., Nguyen H.-O.B., Cohen F.E., Prusiner S.B., and Scott M.R. Elimination of prions by branched polyamines and implications for therapeutics. Proc. Natl. Acad. Sci. USA 96 (1999) 14529-14534
12. Supattapone S., Wille H., Uyechi L., Safar J., Tremblay P., Szoka F.C., Cohen F.E., Prusiner S.B., and Scott M.R. Branched polyamines cure prion-infected neuroblastoma cells. J. Virol. 75 (2001) 3453-3461
13. Solassol J., Crozet C., Perrier V., Leclaire J., Béranger F., Caminade A.-M., Meunier B., Dormont D., Majoral J.-P., and Lehmann S. Cationic phosphorus-containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie. J. Gen. Virol. 85 (2004) 1791-1799
14. Loup C., Zanta M.A., Caminade A.M., Majoral J.P., and Meunier B. Preparation of water-soluble cationic phosphorus-containing dendrimers as DNA transfecting agents. Chem. Eur. J. 5 (1999) 3644-3650
15. Lasmezas C.I., Cesbron J.Y., Deslys J.P., Demaimay R., Adjou K.T., Rioux R., Lemaire C., Locht C., and Dormont D. Immune system-dependent and -independent replication of the scrapie agent. J. Virol. 70 (1996) 1292-1295
16. LeVine III H. Thioflavin T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2 (1993) 404-410
17. Krebs M.R.H., Bromley E.H.C., and Donald A.M. The binding of thioflavin T to amyloid fibrils: localisation and implications. J. Struct. Biol. 149 (2005) 30-37
18. Selvaggini C., De Goia L., Cantu L., Ghibaudi E., Diomede L., Passerini F., Forloni G., Bugiani O., Tagliavini F., and Salmona M. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem. Biophys. Res. Commun. 194 (1993) 1380-1386
19. Salmona M., Malesani P., De Goia L., Gorla S., Bruschi M., Molinari A., della Vedova F., Pedrotti B., Marrari M.A., Awan T., Bugiani O., Forloni G., and Tagliavini F. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126. Biochem. J. 342 (1999) 207-214
20. Masel J., and Jansen V.A.A. Designing drugs to stop formation of prion aggregates and other amyloids. Biophys. Chem. 88 (2000) 47-59
21. Heegaard P.M.H., Pedersen H.G., Flink J., and Boas U. Amyloid aggregates of the prion peptide PrP106-126 are destabilised by oxidation and by the action of dendrimers. FEBS Lett. 577 (2004) 127-133
22. Klajnert B., Cortijo-Arellano M., Bryszewska M., and Cladera J. Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer's and prion diseases. Biochem. Biophys. Res. Commun. 339 (2006) 577-582
23. Klajnert B., Cortijo-Arellano M., Cladera J., and Bryszewska M. Influence of dendrimer's structure on its activity against amyloid fibril formation. Biochem. Biophys. Res. Commun. 345 (2006) 21-28
24. Klajnert B., Cladera J., and Bryszewska M. Molecular interactions of dendrimers with amyloid peptides: pH dependence. Biomacromolecules 7 (2006) 2186-2191
25. Kuznetsov I.B., and Rackovsky S. Comparative computational analysis of prion proteins reveals two fragments with unusual structural properties and a pattern of increase in hydrophobicity associated with disease-promoting mutations. Protein Sci. 13 (2004) 3230-3244
26. Mahfoud R., Garmy N., Maresca M., Yahi N., Puigserver A., and Fantini J. Identification of a common sphingolipid-binding domain in Alzheimer, prion, and HIV-1 proteins. J. Biol. Chem. 277 (2002) 11292-11296
27. Sabate R., Gallardo M., and Estelrich J. An autocatalytic reaction as a model for the kinetics of the aggregation of beta-amyloid. Biopolymers 71 (2003) 190-195
28. 13C NMR. Protein Sci. 9 (2000) 867-877
29. Elliot A., and Ambrose E.J. Structure of synthetic polypeptides. Nature 165 (1950) 921-922
30. Ambrose E.J., and Elliot A. Infrared spectroscopic studies of globular protein structure. Proc. R. Soc. Lond. Ser. A 208 (1951) 75-90
31. Kirkitadze M.D., Condron M.M., and Teplow D.B. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. J. Mol. Biol. 312 (2001) 1103-1119
32. Fraser P.E., McLachlan D.R., Surewicz W.K., Mizzen C.A., Snow A.D., Nguyen J.T., and Kirschner D.A. Conformation and fibrillogenesis of Alzheimer Abeta peptides with selected substitution of charged residues. J. Mol. Biol. 244 (1994) 64-73
33. Sethi S., Lipford G., Wagner H., and Kretzschmar H. Postexposure prophylaxis against prion disease with a stimulator of innate immunity. Lancet 360 (2002) 229-230